Synapsoft logo
AI Insights from Disclosures
Searching...
Vaxcell-Bio Therapeutics 323990
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Vaxcell-Bio Therapeutics, established on February 18, 2010 as a company specializing in the development of anticancer immune cell therapies, develops treatments that activate or strengthen the human immune system to induce immune cells to attack cancer cells. Based on its long-standing research and development on anticancer immune cell therapies, the company has built its pipeline around representative components that can achieve the best effect within the immune system.
Representative Director 이제중 (단독 대표이사)
Founded February 18, 2010
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 20521-0029832
Business number 408-81-85541
Phone Number 061-373-0046
Fax Number 061-372-4946
Company Address 98-1 Sandan-gil, Hwasun-eup, Hwasun-gun, Jeonnam-Gwangju
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant